You are here

  • Home
  • Archive
  • Volume 103, Issue 1
  • Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere

Article metrics

Article menu
Download PDFPDF
Review
Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere

 

Online download statistics by month:

Online download statistics by month: August 2017 to December 2022

AbstractFullPdf
Aug 2017198197
Sep 20171101137123
Oct 2017102658115
Nov 20178065952
Dec 20175517149
Jan 201872710475
Feb 20184974956
Mar 20183926235
Apr 20183003654
May 20182803326
Jun 20182434230
Jul 20182824023
Aug 20182621922
Sep 20183523725
Oct 20186344026
Nov 20186093331
Dec 20183511019
Jan 20194052716
Feb 2019373238
Mar 2019519366
Apr 201928213312
May 201926326424
Jun 201925724018
Jul 2019449145
Aug 20194322114
Sep 20195821710
Oct 201911672912
Nov 2019829259
Dec 2019642101
Jan 2020699238
Feb 2020675215
Mar 2020717197
Apr 202058266
May 202028333
Jun 202015286
Jul 202090108
Aug 202013540
Sep 202027154
Oct 202034472
Nov 202015653
Dec 202012011
Jan 202115872
Feb 202126379
Mar 202127596
Apr 202114379
May 202193118
Jun 202136115
Jul 20212551
Aug 20212843
Sep 202118126
Oct 202134961
Nov 2021405132
Dec 202118213
Jan 2022192305
Feb 202213351
Mar 202218967
Apr 202213183
May 2022138126
Jun 202211590
Jul 2022113105
Aug 202213962
Sep 202212542
Oct 202214343
Nov 20221051112
Dec 20228500
Total2356419981047